Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia - Concepedia

Concepedia

Publication | Open Access

Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia

DOI Full Paper Access

78

Citations

29

References

2013

Year

Kevin R. Kelly, Thomas C. Shea, André Goy, Jesús G. Berdeja, Craig B. Reeder, Kevin T. McDonagh, Xiaofei Zhou, Hadi Danaee, Hua Liu, Jeffrey Ecsedy,

Investigational New Drugs

References

	Year	Citations

Page 1